BackCatabasis Pharmaceuticals Overview

Catabasis Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for CATB.

Quarterly SG&A Expenses

$10.66M

As of Sep 30, 2025

Annual SG&A Expenses (TTM)

N/A

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin